, European Journal of Histochemistry M cells are found in intestinal follicle associated epithelium. Studies into the physiological and pathological roles of human M cells have been hampered by the lack of well-substantiated, specific markers for these cells. A critical literature review suggests the following molecules may potentially serve as such markers: CK7, FcaR (CD89), S100, CD1a, CD21, CD23, sialyl Lewis A, and cathepsin E. Normal ileum, appendix and colorectum were studied using paraffinembedded, formalin-fixed tissue and immunohistochemistry for these 8 markers. Cathepsin E immunohistochemistry was also performed on cases of colorectal adenocarcinoma, colorectal adenoma, colorectal hyperplastic/metaplastic polyp, lymphocytic colitis, collagenous colitis, pseudomembranous colitis and active ulcerative colitis. Of the 8 markers tested, only cathepsin E appeared to be specific to follicle associated epithelium (expressed by cells with and without M cell morphology) and follicular crypt epithelium; this specificity was limited to the colorectum. Focal epithelial expression of cathepsin E was seen in adenocarcinoma, adenoma, hyperplastic/metaplastic polyp, ulcerative colitis and pseudomembranous colitis. In conclusion, cathepsin E is a specific marker of normal colorectal follicle associated epithelium and follicular crypt epithelium though is not specific to M cells within these compartments. None of the other 7 markers studied is exclusively expressed by human M cells.
M cells ('membranous' or 'microfold' cells) are specialised epithelial cells normally found in the epithelium (so called follicle associated epithelium) overlying intestinal mucosal lymphoid follicles (Neutra 1998 , Nicoletti 2000 . Such lymphoid follicles and, hence, M cells are particularly common in the ileum and appendix but are also found in the colorectum (Neutra 1998 , Nicoletti 2000 . Compared with normal enterocytes and colonocytes, M cells show a handful of distinct morphological features. First, M cells possess a less well developed apical brush border with shorter microvilli and reduced expression of brush border associated proteins (Neutra 1998 , Nicoletti 2000 . Second, M cells often show basolateral indentations or 'pockets' which contain lymphocytes of T and/or B cell type (Neutra 1998 , Nicoletti 2000 . These morphological features are in keeping with the principal function of M cells known so far, namely transportation of antigens and microbes across intestinal epithelium (Neutra 1998 . Much, however, remains to be learnt about the role of human M cells in physiological and pathological states. In particular, it has been suggested that M cells represent the entry point of prion proteins from the intestinal lumen (Shmakov et al. 2001) and that a unique subtype of colorectal carcinoma arises from follicle associated epithelium .
Attempts at extending our knowledge of human M cell function and pathology have, in part, been hampered by the lack of a specific marker for such cells. There have been attempts to apply M cell markers of other species to human tissue. However, it is well recognised now that there is wide variation in marker expression between M cells of different species and even between M cells at different sites within the same species. Markers that have been tested so far (reviewed in Table 1 ) may be divided into 4 main groups: i) those related to cytosolic filaments; ii) those related to glycoproteins; iii) those related to the ability of M cells to bind IgA; and iv) a more heterogeneous group related to the cells' interactions with lymphocytes. Of these previous attempts to characterise a human M cell specific marker, the most promising involve sialyl Lewis A and cathepsin E, an aspartic proteinase potentially involved in antigen processing and presentation (Bennet et al. 1992) . However, in each case, the positive results have been presented in only one paper and have not been confirmed since (Finzi et al. 1993 , Giannasca et al. 1999 .
A review of M cell features and putative functions compared with those of enterocytes and colonocytes suggests other molecules that deserve investigation as possible M cell markers. Cytokeratin 7 (CK7) is one such molecule based on the specificity of certain cytokeratin subtypes to M cells in various species (see Table 1 ) and the lack of CK7 expression by normal enterocytes and colonocytes (Osborn et al. 1986) . A previous study suggested CK7 was not expressed by human M cells (Kucharzik et al. 1998 ) but only appendiceal tissue was analysed. Further, preliminary studies in our laboratory have shown focal but unequivocal expression of CK7 in the follicle associated epithelium of human appendices. FcaR (CD89) shows specific binding to IgA (Morton et al. 1996) and while its expression was not demonstrated in a colorectal carcinoma cell line (Kitamura et al. 2000) , such expression has not been looked for amongst normal enterocytes and colonocytes and certainly not amongst M cells. Finally, in view of possible roles for M cells in antigen processing and presentation (Neutra 1998) , it may be hypothesised that the cells express similar molecules to certain antigen presenting cells, e.g. S100 and CD1a (as expressed by Langerhans cells) and CD21 and CD23 (as expressed by follicular dendritic cells). The aims of this study were, therefore, to 1) investigate whether FcaR, S100, CD1a, CD21 and CD23 may serve as specific markers for human intestinal M cells; and 2) to retest the hypotheses that CK7, sialyl Lewis A and cathepsin E represent such markers.
Materials and Methods
Paraffin-embedded, formalin-fixed blocks were collected from the following human tissues: terminal ileum (10 cases), appendix (10 cases), and colorectum (5 cases from right colon and 5 cases from left colon/rectum). These cases had been selected because haematoxylin and eosin-stained sections of all cases (reviewed by NW) were normal. All cases represented surgical resection specimens. When collected from specimens containing neoplasia, only tissue at a distance from the neoplasm was chosen. For cathepsin E immunohistochemistry (see below), paraffin-embedded, formalin-fixed blocks were also collected from cases of the following human colorectal diseases: adenocarcinoma (3 microsatellite unstable and 3 microsatellite stable cases), adenoma (8 cases), hyperplastic/metaplastic polyp (5 cases), collagenous colitis (5 cases), pseudomembranous colitis (5 cases), active ulcerative colitis (5 cases) and lymphocytic colitis (5 cases). Study of the above, anonymised tissues was carried out in accordance with guidelines of the Lothian Local Research Ethics Committee.
Three µm thick sections were cut from the tissue blocks and used for immunohistochemistry. The monoclonal antibody CA19-9 is targeted against sialyl Lewis A ( Allen et al. 1987 , Shimono et al. 1994 . Being widely available and having been extensively used in previous immunohistochemical studies of human intestine (Allen et al. 1987 , Shimono et al. 1994 ), CA19-9 was chosen to study expression of this glycoprotein. Specific details of the immunohistochemical protocols used for the markers studied are shown in Table 2 . All tissue sections for immunohistochemistry were dewaxed and rehydrated, and then subjected to antigen retrieval, except for S100. Endogenous peroxidase was then blocked with 1% hydrogen peroxide in methanol (10 min), and endogenous avidin/biotin blocked (15 min each for each blocking fluid) using the Vector A/B Blocking Kit (Vector Laboratories, Peterborough, UK). Following incubation with primary antibody (Table 2 ) diluted in a commercial antibody diluent (Dako, Ely, UK), the sections were incubated for 30 minutes with biotinylated secondary antibody diluted in commercial antibody diluent (Dako): for cathepsin E, rabbit anti-goat antibody (Dako) at a 1:500 concentration; for S100, swine anti-rabbit antibody (Dako) at a 1:500 concentration; and for all others, rabbit anti-mouse antibody (Dako) at a 1:400 concentration. Visualisation was achieved using commercial ABC (Vector, 30 minutes) and DAB reagents (Dako, 5 minutes) with Mayer's haematoxylin as a counterstain. Normal
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Original Paper Table 2 . Specific details of immunohistochemistry protocols for markers studied. Otherwise, a common protocol was used for all the markers, as described in the main text. lymph node was used as a positive control for CD21 and CD23, a pancreatic adenocarcinoma as a positive control for CA19-9 and CK7, normal tonsil as a positive control for cathepsin E, inflamed appendix as a positive control for FcaR, and normal skin as a positive control for CD1a and S100. Negative controls comprised sections incubated in antibody diluent (Dako) without primary antibody. The immunostained sections were assessed by a gastrointestinal pathologist (NW). M cells were identified morphologically by their location in follicle associated epithelium, absence of a developed apical brush border, and the presence of lymphocytes in their basolateral compartments/pockets.
Marker

Results
Cathepsin E
Cathepsin E immunoreactivity was only seen in the cytoplasmic compartment. Such immunoreactivity was present in follicle associated epithelial cells in all 10 normal colorectal samples ( Figure  1a ) but only in 6/10 normal ileal samples and 7/10 normal appendiceal samples. Where present, up to 25% of follicle associated epithelial cells showed cathepsin E expression. Cathepsin E positive epithelial cells were occasionally seen in ileal villi distant from lymphoid follicles (4/10 ileal samples, Figure  1b ) and in crypts unrelated to lymphoid tissue (4/10 appendiceal samples, Figure 1c ), hereafter referred to as non-follicular villi and crypts, respectively. In the 10 normal colorectal samples studied, cathepsin E immunoreactivity was never seen in epithelium unrelated to lymphoid tissue; cathepsin E was occasionally expressed by cells lacking a classical M cell morphology but such cells were either located in the follicle associated epithelium or in crypt epithelium within lymphoid follicles (Figure 1a) .
Two of the 3 microsatellite stable and 2 of the 3 microsatellite unstable colorectal carcinomas showed cathepsin E expression (Figure 1d) . The staining was focal in all 4 cases and, in one tumour, was limited to its mucinous component. Cathepsin E expression was seen in 7/8 colorectal adenomas (Figure 1e ) and 4/5 hyperplastic/metaplastic polyps ( Figure 1f ). Staining was focal in all the positive cases and, amongst the adenomas, was predominantly found in the superficial epithelium (Figure 1e ). Four of the 5 cases of active ulcerative colitis showed cathepsin E expression (Figure 1g ). This expression was focal and present both in surface and crypt epithelium. Focal cathepsin E expression was present in 4/5 cases of pseudomembranous colitis, both in atrophic crypts and epithelium adjacent to ulceration (Figure 1h) . Cathepsin E staining was not seen in any of the cases of lymphocytic colitis or of collagenous colitis.
CA19-9 (sialyl Lewis A)
Diffuse immunoreactivity was present in goblet cell contents and along epithelial cell apical membranes in all 10 normal ileal samples, 3/10 normal appendiceal samples and 1/10 normal colorectal samples (Figure 2a) . Cytoplasmic immunoreactivity was seen in scattered epithelial cells within normal ileal, appendiceal and colorectal crypts, including those at a distance from lymphoid follicles (Figure 2b) . Because of the diffuse nature of CA19-9 immunoreactivity in the ileal specimens, no differences in staining pattern were evident between M cells and enterocytes. M cells lacking immunoreactivity for CA19-9 were readily identified in the normal appendiceal and colorectal cases.
CK7
Where present, CK7 expression was seen along cell membranes and in the cytoplasm. CK7 was expressed by occasional epithelial cells within normal appendiceal follicle associated epithelium (Figure 2c ). However, several appendiceal M cells lacked CK7 immunoreactivity (Figure 2c) , and occasional CK7-positive epithelial cells were also present within non-follicular crypts in the appendix (Figure 2d ). CK7 was not expressed by follicle associated epithelium or follicular crypt epithelium of normal ileum or colorectum.
Other markers
FcaR, S100, CD1a, CD21 and CD23 were not expressed in follicle associated epithelium or follicular crypt epithelium in any of the normal ileal, appendiceal or colorectal cases studied.
Discussion
We have investigated a wide range of potential specific markers for human intestinal M cells. A potential criticism of our study is its lack of ultrastructural analyses, which remain the gold standard for the identification of M cells within follicle associated epithelium ). In the cases of CA19-9 and CK7, however, their expression in non-follicular crypts and/or villi refuted the specificity of these potential markers; precise identification of M cells in follicle associated epithelium was therefore irrelevant. A similar argument applied to cathepsin E in the normal appendix, normal ileum and diseased colorectum. Finally, the presence of cathepsin E in follicular crypt epithelium of normal colorectum and in a greater proportion of colorectal follicle associated epithelial cells than would be expected, i.e. 10% , indicated the marker was not specific to M cells within these compartments. All our conclusions were, therefore, robust and did not require confirmation with ultrastructural analyses.
We have found cathepsin E to be a specific marker of follicle associated epithelium and follicular crypt epithelium in the normal colorectum but not in the ileum or appendix. These findings mirror the regional specificity of several animal M cell markers (Table 1 ). The nature of the non-follicular, cathepsin E positive cells in ileal and appendiceal epithelium is uncertain. However, Finzi and colleagues have described similar cells in the ileum and suggest they represent cup cells (Finzi et al. 1993) which, like M cells, may be involved in the transportation of antigens and microbes across the intestinal epithelium (Madara et al. 1985) . The presence of cathepsin E in cells that handle antigen is in keeping with a potential role for the protease in antigen processing (Bennet et al. 1992) . Such a role may explain our observation of more widespread epithelial expression of cathepsin E in inflammatory conditions such as active ulcerative colitis and pseudomembranous colitis. This expression could be a non-specific response to acute inflammation and ulceration per se rather than being specific to these disease entities. Absence of cathepsin E expression in lymphocytic colitis would certainly be consistent with such expression being related only to acute inflammation. We had also been interested to see whether an M cell marker might be overexpressed in lymphocytic colitis because previous in vitro studies suggest lymphocytes may induce M cell differentiation in intestinal epithelial cells (Gullberg et al. 2000) . Our negative findings, however, should only be cautiously compared with the in vitro data as T lymphocytes are the predominant cell found in lymphocytic colitis whereas a neoplastic B cell line was used in the co-culture experiments (Gullberg et al. 2000) .
To the best of our knowledge, cathepsin E expression in neoplastic colorectal tissue has not been previously described. As mentioned earlier, Jass and colleagues have recently described a subtype of colorectal carcinoma which is thought to derive from follicle associated epithelium (Clouston et al. 2000 . At least two factors, however, make it unlikely that the cathepsin E expression we observed in 4 carcinomas was due to such a derivation. First, none of these 4 carcinomas showed the distinctive morphological features (e.g. prominent lymphoid infiltrate) of Jass's follicle associated epithelium-derived colorectal carcinomas (Clouston et al. 2000 . Second, none of Jass's carcinomas appeared to derive from pre-existing adenoma (Clouston et al. 2000 ; the expression of cathepsin E in our sporadic colorectal adenomas therefore suggests such expression to be a feature of the 'standard' adenoma-carcinoma sequence rather than a unique pathway involving follicle associated epithelium. The presence of cathepsin E in hyperplastic/metaplastic polyps is in keeping with the gastric-like phenotype shown by these polyps (Yao et al. 1999 ) and the normal expression of the protease in gastric foveolar epithelium (Samloff et al. 1987 ).
As mentioned above, the presence of cathepsin E in M cells would be in keeping with possible roles in antigen processing and presentation. In spite of such roles, we failed to apply markers of other antigen presenting cells to M cells or follicle associated epithelium as a whole. We also failed to utilise the fact that IgA binds specifically to M cells (Weltzin et al. 1989 ) to find a specific marker for these cells. The receptor for IgA on M cells therefore remains unknown. Despite initial promising findings, non-follicular epithelial expression of CK7 precluded its use as a specific marker for appendiceal M cells. That a previous study failed to show any expression of CK7 at all in appendiceal mucosa may be due to the authors' use of frozen tissue immunohistochemistry and a different antibody (Kucharzik et al. 1998) . Again, use of a different antibody might explain our failure to confirm the findings of Giannasca and colleagues that sialyl Lewis A is a specific marker of human M cells (Giannasca et al. 1999) .
In summary, of a large panel of markers tested, only cathepsin E was found to be specific to follicle associated epithelium and follicular crypt epithelium. However, this specificity was restricted to normal colorectum and the marker did not distinguish between M cells and other follicle associated epithelial or follicular crypt epithelial cells. Our study has shown, for the first time, that cathepsin E expression is aberrantly expressed both in actively inflamed and in neoplastic colorectal epithelium. The pathophysiological significance of these preliminary findings will require further study.
